Recursion Pharma Inc (Class A) - RXRX - stock price prediction, stock price target, analyst ratings from 8 analysts

Recursion Pharma Inc (Class A) has a share price target of US$ 7, revenue growth forecast of 4.7%, and profit growth estimate of -43.6% for FY25, based on top 8 analyst calls.